Reach Us +447480022765
Kay Tetzlaff | OMICS International
ISSN: 2161-105X

Journal of Pulmonary & Respiratory Medicine
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Kay Tetzlaff

Boehringer Ingelheim Pharma GmbH & Co. KG Germany


Dr.Kay is a highly experienced pharmaceutical professional with expertise in respiratory drug development spanning from early clinical through pivotal phase III programs. Kay was an outstanding mentor while working together on early translational clinical projects and multinational phase IIa PoC studies. He is the Senior Clinical Program Leader, Therapeutic Area Respiratory in Boehringer Ingelheim.

Research Interest

Allergology, Pulmonology, Respiratory Medicine, Respiratory drugs, Lung diseases, Lung, Pulmonary diseases